Sort
51,570 grants matching “autoimmune disease”
Advancing BITT-101 a novel dominant CD40 antagonist for use in treatment of Sjogren Syndrome.
$926,858Kenneth Olivier · Boston Immune Technologies And Therapeutics, Inc. · R44 · FY2025 · AI
Mechanisms of sphingolipid signaling in vascular health and disease
$926,656Timothy Tun Hla · Boston Children'S Hospital · R35 · FY2017 · HL
Human Genetic Analysis Resource
$926,451Case Western Reserve University · P41 · FY2004 · RR
Pathophysiology of HTLV-I and HTLV-II Infection
$925,969Edward L Murphy · University Of California, San Francisco · R01 · FY2006 · HL
Rituximab for Anticytokine Autoantibody-Associated Syndromes
$925,647Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Assessment, Therapy and Prevention Of Autoimmune Disease
$925,251Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES
Signaling via MHC: engineering immune cells with new capabilities
$925,233Alok Joglekar · University Of Pittsburgh At Pittsburgh · DP2 · FY2025 · AI
TISSUE INJURY AND INFLAMMATION IN MULTIPLE SCLEROSIS
$925,059Cleveland Clinic Foundation · P01 · FY2002 · NS
Role of the microbiota in regulating the mononuclear phagocyte system
$925,047Silvana Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
MOLECULAR BASIS OF IDIOPATHIC DRY MOUTH
$924,028University Of Rochester · P01 · FY2002 · DE
Validation of Novel Peptide/Protein Markers for Diagnosis of Type 1 Diabetes
$923,787Thomas O Metz · Battelle Pacific Northwest Laboratories · R56 · FY2012 · DK
IND-enabling assay validation and toxicology studies on AKS-107: a novel antigen-specific B cell therapeutic to prevent Type 1 Diabetes
$923,642Todd C Zion · Akston Biosciences Corporation · R44 · FY2020 · DK
Mapping Drug Resistance Genes in Plasmodium falciparum
$923,047Tim J Anderson · Texas Biomedical Research Institute · R37 · FY2017 · AI
Mapping Drug Resistance Genes in Plasmodium falciparum
$923,047Tim J Anderson · Texas Biomedical Research Institute · R37 · FY2020 · AI
Mapping Drug Resistance Genes in Plasmodium falciparum
$923,047Tim J Anderson · Texas Biomedical Research Institute · R37 · FY2019 · AI
Mapping Drug Resistance Genes in Plasmodium falciparum
$923,047Tim J Anderson · Texas Biomedical Research Institute · R37 · FY2021 · AI
Phenotype MicroArray Analysis of Fastidious Pathogens
$923,041Barry Ronald Bochner · Biolog, Inc. · R42 · FY2009 · GM
Pathophysiology of HTLV-I and HTLV-II Infection
$923,015Edward L Murphy · University Of California, San Francisco · R01 · FY2007 · HL
A Novel Immunologically Enhanced Probiotic for Treating Rheumatoid Arthritis
$922,693Gary Fanger · Rise Therapeutics, Llc · R44 · FY2023 · AI
STEM CELLS FOR TOLERANCE INDUCTION
$922,666University Of Miami School Of Medicine · U19 · FY2003 · AI
Human Genetic Analysis Resource
$922,558Robert C. Elston · Case Western Reserve University · P41 · FY2009 · RR
Immunomodulatory Therapy for Neuropathic Pain
$922,476Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2022 · NS
Application Of Mass Spectrometry To Structural Biology
$922,399Kenneth Tomer · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Neurodegeneration Underlying Distinct Disabilities in Multiple Sclerosis Using a Cell-Specific, Region-Specific, and Sex-Specific Approach
$922,109Rhonda R Voskuhl · University Of California Los Angeles · R35 · FY2025 · NS
The role of apoptosis in B lymphocyte biology
$922,085Christian Mayer · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA